miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.
about
A three-microRNA signature as a diagnostic and prognostic marker in clear cell renal cancer: An In Silico analysisThe miR-29 transcriptome in endocrine-sensitive and resistant breast cancer cells.SNCA Is a Functionally Low-Expressed Gene in Lung Adenocarcinoma.LGR4 modulates breast cancer initiation, metastasis, and cancer stem cells.miR-367 stimulates Wnt cascade activation through degrading FBXW7 in NSCLC stem cells.Bioinformatics-based identification of miR-542-5p as a predictive biomarker in breast cancer therapy.Elevated miR-301a expression indicates a poor prognosis for breast cancer patients.Nogo-B receptor increases the resistance of estrogen receptor positive breast cancer to paclitaxel.KIAA0247 inhibits growth, migration, invasion of non-small-cell lung cancer through regulating the Notch pathway.TRPM2 channel-mediated regulation of autophagy maintains mitochondrial function and promotes gastric cancer cell survival via the JNK signaling pathway.Src-mediated phosphorylation converts FHL1 from tumor suppressor to tumor promoter.STAT3, stem cells, cancer stem cells and p63.The orphan GPR50 receptor promotes constitutive TGFβ receptor signaling and protects against cancer development.Role of MicroRNA in Proliferation Phase of Wound Healing.MCP-1 is overexpressed in triple-negative breast cancers and drives cancer invasiveness and metastasis.Prognostic value of alcohol dehydrogenase mRNA expression in gastric cancer.Distinct Expression and Prognostic Value of MS4A in Gastric Cancer.NOTCH-mediated non-cell autonomous regulation of chromatin structure during senescence.Association of miR-548c-5p, miR-7-5p, miR-210-3p, miR-128-3p with recurrence in systemically untreated breast cancer.Cytokeratin 19 (KRT19) has a Role in the Reprogramming of Cancer Stem Cell-Like Cells to Less Aggressive and More Drug-Sensitive Cells.Somatic mutations in early onset luminal breast cancer.Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets.Candidate genes in gastric cancer identified by constructing a weighted gene co-expression network.Identification of endothelial selectin as a potential prognostic marker in breast cancer.SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer.MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer.MicroRNA-493 is a prognostic factor in triple-negative breast cancer.KM-express: an integrated online patient survival and gene expression analysis tool for the identification and functional characterization of prognostic markers in breast and prostate cancers.Systematic expression alteration analysis of master reprogramming factor OCT4 and its three pseudogenes in human cancer and their prognostic outcomesExpressions and prognostic values of the transcription factors in human breast carcinomaComparison of breast cancer metastasis models reveals a possible mechanism of tumor aggressivenessMetastatic growth instructed by neutrophil-derived transferrinProteomic analysis of the OGT interactome: novel links to epithelial-mesenchymal transition and metastasis of cervical cancerMiR-29b-1-5p is altered in BRCA1 mutant tumours and is a biomarker in basal-like breast cancerIdentification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics AnalysisEstrogen receptor-beta is a potential target for triple negative breast cancer treatmentTargeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistanceExploring prognostic genes in ovarian cancer stage-related coexpression network modulesTranscriptomic but not genomic variability confers phenotype of breast cancer stem cellsPrediction of key genes and pathways involved in trastuzumab-resistant gastric cancer
P2860
Q33853938-88A91813-019E-4B0B-9824-8E6E56A5440CQ38431320-91AFE42C-FAD9-4E88-A0FC-5466112F7834Q47210545-C3AA107D-4DF9-46E2-B7D4-32C7A42778A8Q47561597-19CDC712-CCFF-4E35-B3EE-6FE752459EA4Q47757966-BCA23931-AB4A-4CBE-8F6B-809521BDC192Q49163340-CFF696CE-0E73-4A47-A609-33518346E2F0Q49357950-BF5B4231-C4C0-4435-8582-8588E28BC5AAQ49649617-6525D14C-89A3-4BA0-B4D6-CAAB24F84471Q49928483-A35807DE-224A-4E74-B35A-0D4E9CFDA59BQ49990399-7F8E64F6-DDD5-4D06-9E19-885DF37EA9DCQ50046229-CEE0CD4A-C8D1-4316-B040-15F009FA2C5DQ52339863-A5B97F77-B080-4596-A68D-ADBAF8143EF1Q52343928-041ABAC3-8275-4ACC-9224-C53E53CB1E41Q52371311-5851EC5D-90FF-4F53-BDEE-A429903C537CQ52623670-A7C29A46-013D-4F0D-BA7D-AE648ACF2E63Q52649695-0C6CC0B8-9A76-4DC0-82A2-AE72A24008B5Q53821747-F5DC73BB-BF56-44BE-A827-2E121C0ED4FEQ54965975-041657B6-4023-44F2-BBA8-E011D7435245Q55011586-10167307-5244-4EC5-B41C-FEED8D2F6FF8Q55143746-69CB02DB-6FE3-41D2-B399-F636A15C3824Q55280468-AF5DB3B9-F8A6-4E07-B318-0F0A11CF00C3Q55332393-8BBBF243-157C-4A71-AF0D-7B526DA749B5Q55346557-8FC05997-1B95-4E91-8C3A-0816AB426D01Q55360086-9320BAF5-0762-4823-82D0-819A06258BBFQ55360446-7C068DE8-2115-4A04-B401-903DFAFC5B99Q55455064-B70ED6CC-B87D-4EFF-B533-996F0AB68BD3Q55518168-35CD10C3-7687-4C89-9FCB-37B73E7C450DQ55716944-CFE125E3-381A-461F-92FE-1B55A11A21E7Q57032028-B0612A82-F65B-457A-8F6E-3726A3DD9D39Q57075023-4048B9A2-FE34-445A-9D05-AA7A38B1C170Q57283075-F1547D5F-3202-4DCE-98E4-68E51311DD11Q57292191-DDFBC1DF-0631-486C-9645-969A7D461DB7Q57293808-1AD60ADC-FA9A-4892-9975-993C24F0624EQ57493676-94009462-EFC6-4971-9167-5E8A9CFBF2D2Q58122535-F2739C43-07D1-4A4B-BBEB-BDD9A0D623B9Q58553027-3ABD1B59-F30C-45A1-8903-0D01F6390A31Q58617565-6D5D1FA0-01B0-4045-9BCA-F11035305E6BQ58706435-0F0CAB20-FD86-48C9-B252-9DC71D41A855Q58719182-2EA9A2D0-AD50-40DC-BDAE-71688F5820A0Q58720903-119CA514-1BA1-43AB-956F-2F9A1A6E6AF2
P2860
miRpower: a web-tool to validate survival-associated miRNAs utilizing expression data from 2178 breast cancer patients.
description
2016 nî lūn-bûn
@nan
2016 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
miRpower: a web-tool to valida ...... m 2178 breast cancer patients.
@ast
miRpower: a web-tool to valida ...... m 2178 breast cancer patients.
@en
type
label
miRpower: a web-tool to valida ...... m 2178 breast cancer patients.
@ast
miRpower: a web-tool to valida ...... m 2178 breast cancer patients.
@en
prefLabel
miRpower: a web-tool to valida ...... m 2178 breast cancer patients.
@ast
miRpower: a web-tool to valida ...... m 2178 breast cancer patients.
@en
P2093
P2860
P1476
miRpower: a web-tool to valida ...... m 2178 breast cancer patients.
@en
P2093
András Lánczky
András Szabó
Balázs Győrffy
Giulia Bottai
Gyöngyi Munkácsy
Libero Santarpia
P2860
P2888
P304
P356
10.1007/S10549-016-4013-7
P407
P577
2016-10-15T00:00:00Z
P6179
1020937291